Status: Recruiting
Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis
This study aims to compare the efficacy and safety of the combination drug Clotrimazole+Lactulose with the monocomponent product Canesten® (clotrimazole) in adult women diagnosed with candidal vulvovaginitis. The primary objective was to confirm the superiority of the combination drug in terms of clinical and microbiological response on Day 25 of the study.
Participants needed: 264
Trial details
Phase: Phase 2, Phase 3Age: 18-60Biological sex: FemaleType: InterventionalSponsor: AVVA Pharmaceuticals Ltd.Updated: Feb 19, 2025Locations: 7
Eligibility criteria
Women aged 18 to 60 years. [+4]
Pregnancy or breastfeeding. [+4]